873551-53-2

873551-53-2 structure
873551-53-2 structure
  • Name: FTIDC
  • Chemical Name: FTIDC
  • CAS Number: 873551-53-2
  • Molecular Formula: C18H23FN6O
  • Molecular Weight: 358.413
  • Catalog: Signaling Pathways GPCR/G Protein mGluR
  • Create Date: 2018-06-10 03:36:42
  • Modify Date: 2024-01-10 17:42:53
  • FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1[1].

Name FTIDC
Synonyms 4-[1-(2-Fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydro-1(2H)-pyridinecarboxamide
1(2H)-Pyridinecarboxamide, 4-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-3,6-dihydro-N-methyl-N-(1-methylethyl)-
FTIDC
Description FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC50 of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1[1].
Related Catalog
Target

mGluR1a:5.8 nM (IC50)

mGluR5:6200 nM (IC50)

In Vitro FTIDC inhibits L-glutamate-induced increases in intracellular Ca2+ concentrations, with IC50 values of 5.8 nM , 5.8 nM , 3.1 nM , 7.7 nM for human mGluR1a, rat mGluR1a, mouse mGluR1a, human mGluR1b in CHO cells, respectively[1].
In Vivo FTIDC (i.p. or p.o.; 1-30 mg/kg) reduces the duration of face-washing behavior elicited in a dosedependent manner and the inhibitory effect is statistically significant at 10 and 30 mg/kg with i.p. and 30 mg/kg with p.o.[1]. Animal Model: Male CD1 (ICR) mice of 6-weeks-old[1] Dosage: 1, 3, 10, and 30 mg/kg Administration: I.p. or p.o. Result: Reduced the duration of face-washing behavior elicited in a dosedependent manner and was statistically significant at 10 and 30 mg/kg with i.p. and 30 mg/kg with p.o..
References

[1]. Suzuki G, et al. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53.

Density 1.3±0.1 g/cm3
Boiling Point 558.2±60.0 °C at 760 mmHg
Molecular Formula C18H23FN6O
Molecular Weight 358.413
Flash Point 291.4±32.9 °C
Exact Mass 358.191742
LogP 2.15
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.624